Gastroenteritis
MONDO:0002269An inflammatory disorder that affects the upper and lower gastrointestinal tract. Most commonly, this is attributed to viruses; however bacteria, parasites or adverse reactions can also be the culprit. Symptoms include acute diarrhea and vomiting.
Also known as: inflammation of intestine, intestine inflammation, infectious colitis, enteritis and gastroenteritis
838 clinical trials for this condition and its sub-types, 20 tagged with Gastroenteritis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gastroenteritis
-
Colitis 41 trials · 677 incl. sub-types
9 sub-types
- Ulcerative colitis 579 trials Sub-types →
- Infectious colitis 0 trials · 69 incl. sub-types Sub-types →
- Indeterminate colitis 26 trials
- Proctocolitis 2 trials · 7 incl. sub-types Sub-types →
- Ileocolitis 5 trials
- Microscopic colitis 3 trials · 5 incl. sub-types Sub-types →
- Chemical colitis 3 trials
- Diversion colitis 2 trials
- Ischemic colitis 0 trials
-
Appendicitis 76 trials
-
Intestinal infectious disease 3 trials · 49 incl. sub-types
2 sub-types
- Dysentery 12 trials · 33 incl. sub-types Sub-types →
- Cholera 16 trials
-
Inflammatory diarrhea 0 trials · 33 incl. sub-types
1 sub-type
- Dysentery 12 trials · 33 incl. sub-types Sub-types →
-
Enteritis 5 trials · 23 incl. sub-types
3 sub-types
- Small bowel Crohn disease 7 trials · 17 incl. sub-types Sub-types →
- Duodenitis 1 trial · 2 incl. sub-types Sub-types →
- Meckel diverticulitis 0 trials
-
Eosinophilic gastroenteritis 6 trials · 7 incl. sub-types
2 sub-types
- Eosinophilic gastritis 5 trials
- Eosinophilic colitis 2 trials
-
Campylobacteriosis 3 trials
1 sub-type
-
Intestinal tuberculosis 2 trials
-
Salmonella gastroenteritis 0 trials
Most studied deeper sub-types
-
New mRNA vaccine aims to stop the stomach flu
Vaccine OngoingThis large Phase 3 study is testing an mRNA vaccine called mRNA-1403 to prevent norovirus, a common cause of severe stomach upset and diarrhea. About 38,000 adults aged 18 and older will receive either the vaccine or a placebo. The goal is to see if the vaccine can safely prevent…
Phase 3 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
Could a probiotic calm gut inflammation in overweight people?
Disease control By invitation onlyThis study tests a probiotic called Streptococcus thermophilus (FX856) in 100 overweight or obese adults. The goal is to see if it can reduce mild gut inflammation and improve digestive symptoms. Participants will take the probiotic or a placebo in a crossover design, and researc…
Sponsor: University of Ulster • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Last-Resort treatment opens for rare swallowing disorder
Disease control Expanded access (ended)This program offers APT-1011, a fluticasone tablet that dissolves in the mouth, to patients aged 12 and older with eosinophilic esophagitis who cannot join other studies or have not responded to available treatments. The goal is to provide access until the drug is commercially av…
Sponsor: Ellodi Pharmaceuticals, LP • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Beach danger? new study tracks illness from toxic algae
Knowledge-focused OngoingThis study follows 2,500 people who visit freshwater beaches in Ontario, Manitoba, and Nova Scotia to see if contact with water containing blue-green algae (cyanobacteria) leads to stomach bugs, respiratory issues, or skin/eye infections. Researchers will also track illness in pe…
Sponsor: Toronto Metropolitan University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:54 UTC